Current Perspectives On The Role Of The Ketogenic Diet In Epilepsy Management

Jyotindra Narayan Goswami,1 Suvasini Sharma2 1Department of Pediatrics, Army Hospital (Research & Referral), New Delhi 110010, India; 2Neurology Division, Department of Pediatrics, Lady Hardinge Medical College and Associated Kalawati Saran Children’s Hospital, New Delhi 110001, In...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Goswami JN, Sharma S
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2019
Materias:
Acceso en línea:https://doaj.org/article/9a3cf15265c54a008cbeb79ab0dd2d33
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:9a3cf15265c54a008cbeb79ab0dd2d33
record_format dspace
spelling oai:doaj.org-article:9a3cf15265c54a008cbeb79ab0dd2d332021-12-02T05:26:20ZCurrent Perspectives On The Role Of The Ketogenic Diet In Epilepsy Management1178-2021https://doaj.org/article/9a3cf15265c54a008cbeb79ab0dd2d332019-11-01T00:00:00Zhttps://www.dovepress.com/current-perspectives-on-the-role-of-the-ketogenic-diet-in-epilepsy-man-peer-reviewed-article-NDThttps://doaj.org/toc/1178-2021Jyotindra Narayan Goswami,1 Suvasini Sharma2 1Department of Pediatrics, Army Hospital (Research & Referral), New Delhi 110010, India; 2Neurology Division, Department of Pediatrics, Lady Hardinge Medical College and Associated Kalawati Saran Children’s Hospital, New Delhi 110001, IndiaCorrespondence: Suvasini SharmaNeurology Division, Department of Pediatrics, Lady Hardinge Medical College and Associated Kalawati Saran Children’s Hospital, Connaught Place 110001, New Delhi Tel +91-9910234344Email sharma.suvasini@gmail.comAbstract: Drug-refractory epilepsy is a commonly prevalent pediatric neurological illness of global significance. Ketogenic diet (KD) is a time-tested therapeutic modality for refractory epilepsy, which has reemerged as a robust alternative to anti-epileptic pharmacotherapy. There is a growing body of evidence which supports the anti-seizure efficacy, safety profile and feasibility of KD use in childhood epilepsy. In addition, this modality has been recognized to reduce anti-epileptic exposure, improve cognition and behavioral profile of patients as well as improve the quality-of-life of care-givers. Current indications of KD include refractory epilepsy syndromes, selected metabolic disorders (such as pyruvate dehydrogenase deficiency) and a host of varied neurological entities. KD research has broadened the knowledge-base about its mechanisms of action. Four types of KD are in vogue currently with varying nutritional constitution, palatability, administration protocols and comparable efficacy. KD initiation and maintenance are the result of concerted effort of a team of pediatric neurologist/epileptologist, nutritionist and patient’s primary care-giver. Consensus is being formulated about various practical aspects of KD such as patient-selection, parental counseling, baseline work-up, dietary prescription, nutritional supplementation, concurrent anti-epileptic drug administration, follow-up and treatment-duration. Novel applications of KD include its use in neonatal epilepsy and super-refractory status epilepticus and tailor-made formulations such as cooking oil-based KD in predominantly rice-fed populations. Increasing body of clinical experience, improved nutritional designs and translational research are promoting KD as a major therapeutic modality. Currently, KD forms a core essence in the armamentarium against refractory epilepsy. In this review, we summarize the recent advances and current perspectives in the use of KD in refractory epilepsy.Keywords: Modified Atkins Diet, low glycemic index diet, ketosis, intractable epilepsy, epileptic encephalopathies, ketogenic diet, epilepsyGoswami JNSharma SDove Medical Pressarticlemodified atkins dietlow glycemic index dietketosisintractable epilepsyepileptic encephalopathies.Neurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol Volume 15, Pp 3273-3285 (2019)
institution DOAJ
collection DOAJ
language EN
topic modified atkins diet
low glycemic index diet
ketosis
intractable epilepsy
epileptic encephalopathies.
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
spellingShingle modified atkins diet
low glycemic index diet
ketosis
intractable epilepsy
epileptic encephalopathies.
Neurosciences. Biological psychiatry. Neuropsychiatry
RC321-571
Neurology. Diseases of the nervous system
RC346-429
Goswami JN
Sharma S
Current Perspectives On The Role Of The Ketogenic Diet In Epilepsy Management
description Jyotindra Narayan Goswami,1 Suvasini Sharma2 1Department of Pediatrics, Army Hospital (Research & Referral), New Delhi 110010, India; 2Neurology Division, Department of Pediatrics, Lady Hardinge Medical College and Associated Kalawati Saran Children’s Hospital, New Delhi 110001, IndiaCorrespondence: Suvasini SharmaNeurology Division, Department of Pediatrics, Lady Hardinge Medical College and Associated Kalawati Saran Children’s Hospital, Connaught Place 110001, New Delhi Tel +91-9910234344Email sharma.suvasini@gmail.comAbstract: Drug-refractory epilepsy is a commonly prevalent pediatric neurological illness of global significance. Ketogenic diet (KD) is a time-tested therapeutic modality for refractory epilepsy, which has reemerged as a robust alternative to anti-epileptic pharmacotherapy. There is a growing body of evidence which supports the anti-seizure efficacy, safety profile and feasibility of KD use in childhood epilepsy. In addition, this modality has been recognized to reduce anti-epileptic exposure, improve cognition and behavioral profile of patients as well as improve the quality-of-life of care-givers. Current indications of KD include refractory epilepsy syndromes, selected metabolic disorders (such as pyruvate dehydrogenase deficiency) and a host of varied neurological entities. KD research has broadened the knowledge-base about its mechanisms of action. Four types of KD are in vogue currently with varying nutritional constitution, palatability, administration protocols and comparable efficacy. KD initiation and maintenance are the result of concerted effort of a team of pediatric neurologist/epileptologist, nutritionist and patient’s primary care-giver. Consensus is being formulated about various practical aspects of KD such as patient-selection, parental counseling, baseline work-up, dietary prescription, nutritional supplementation, concurrent anti-epileptic drug administration, follow-up and treatment-duration. Novel applications of KD include its use in neonatal epilepsy and super-refractory status epilepticus and tailor-made formulations such as cooking oil-based KD in predominantly rice-fed populations. Increasing body of clinical experience, improved nutritional designs and translational research are promoting KD as a major therapeutic modality. Currently, KD forms a core essence in the armamentarium against refractory epilepsy. In this review, we summarize the recent advances and current perspectives in the use of KD in refractory epilepsy.Keywords: Modified Atkins Diet, low glycemic index diet, ketosis, intractable epilepsy, epileptic encephalopathies, ketogenic diet, epilepsy
format article
author Goswami JN
Sharma S
author_facet Goswami JN
Sharma S
author_sort Goswami JN
title Current Perspectives On The Role Of The Ketogenic Diet In Epilepsy Management
title_short Current Perspectives On The Role Of The Ketogenic Diet In Epilepsy Management
title_full Current Perspectives On The Role Of The Ketogenic Diet In Epilepsy Management
title_fullStr Current Perspectives On The Role Of The Ketogenic Diet In Epilepsy Management
title_full_unstemmed Current Perspectives On The Role Of The Ketogenic Diet In Epilepsy Management
title_sort current perspectives on the role of the ketogenic diet in epilepsy management
publisher Dove Medical Press
publishDate 2019
url https://doaj.org/article/9a3cf15265c54a008cbeb79ab0dd2d33
work_keys_str_mv AT goswamijn currentperspectivesontheroleoftheketogenicdietinepilepsymanagement
AT sharmas currentperspectivesontheroleoftheketogenicdietinepilepsymanagement
_version_ 1718400431071166464